Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Foamix Pharma Ord

(NASDAQ: FOMX)
Add to Portfolio
-0.02 (-0.58%)
as of Nov 15, 2019

Last 3.42
Change -0.02 (-0.58%)
Open 3.43
Prev. Close 3.44
Today's Range
3.20
3.47
52wk Range
1.97
4.48
Volume 980,100
Avg Volume 2,274,140
Sector SIC-2833 Medicinal Chemicals & Botanical Products

Perfomance Comparison

Name Today 3-Month 1-Year
FOMX -0.58% +3.95% -13.20%
DJIA +0.80% +4.51% +10.74%
S&P 500 +0.77% +4.76% +14.29%

Key Statistics

Annual EPS -1.27
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 242,800
Weighted Alpha -21.80
Standard Deviation -0.08
Profit Margin N/A
Beta 1.57

Growth Rates

YTD -4.74%
1-Year -12.53%
3-Year -62.58%
5-Year -35.10%

Opinion

Sell Hold Buy

Recent Headlines

URGENT NEWS: Monteverde & Associates PC Announces an

PR Newswire via COMTEX - Fri Nov 15, 08:00PM EST
Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Foamix Pharmaceuticals, Ltd. ("Foamix" or the "C(full story)
FOMX: 3.42 (-0.02)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies

GlobeNewswire via COMTEX - Wed Nov 13, 04:36PM EST
The following statement is being issued by Levi & Korsinsky, LLP:(full story)
MNLO: 4.36 (unch), FOMX: 3.42 (-0.02)

SHAREHOLDER ALERT: WeissLaw LLP Investigates Foamix

PR Newswire via COMTEX - Tue Nov 12, 05:09PM EST
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Foamix Pharmaceuticals Ltd. ("FOMX" or the "Company") (NASDAQ: FOMX) in connection with the proposed acquis(full story)
FOMX: 3.42 (-0.02), MNLO: 4.36 (unch)